Pharming Group NV

Netherlands Country flag Netherlands
Sector: Biotechnology
Ticker: PHARM
ISIN: NL0010391025
Factsheet Factsheet

Growth Analysis of Pharming Group NV ( PHARM | NLD)

The Growth Score is a relevant measure for the assessment of a stock attractiveness. Pharming Group NV shows a Growth Score of 5.00.
The Growth Score for Pharming Group NV is higher than its peer group's. This means that Pharming Group NV has a higher growth than its peer group.

Valuation
EV/EBITDA LastEV/EBITDA(e) 2021EV/EBITDA NTM
Pharming Group NVFree trialFree trialFree trial
International PeersFree trialFree trialFree trial
Biotechnology-1.01-1.23-0.61
AEX 259.3510.9310.14
Netherlands6.237.116.50
More...
Beta (Ref: AEX 25)
Levered betaUnlevered beta
1-Year0.630.66
2-Year0.680.70
3-Year0.930.96
More...
Stock Perf excl. Dividends (in EUR)
PHARMAEX 25Rel. Perf.
Year-to-Date31.9%-16.7%48.6%
1-Week-6.2%3.6%-9.9%
1-Month-13.0%-1.4%-11.6%
1-Year29.8%-13.8%43.7%
3-Year-16.4%17.7%-34.1%
5-Year38.1%22.5%15.6%
More...
GPRV Analysis
Pharming Group NV
Intl. Peers
U.S Patents No. 7,882,001 & 8,082,201
More...
International Peers - Pharming Group NV
Company NameCtryMarket
Cap.
last (mUSD)
Pharming Group NVNLD661
International Peers Median0.45
Pharvaris NVNLD189
BELLUS Health Inc.CAN1 285
Bavarian Nordic A/SDNK2 042
Biotest AGDEU1 485
Lyell Immunopharma, Inc...USA1 960
Net Sales Chart
More...
Quotes Chart

1-Year Rebased Stock Chart

  • Pharming Group NV
  • AEX 25
More...

About Stock Growth Analysis

Aggregated Growth Score
In GPRV, the aggregated Growth Score is the average of the growth indicators' scores.

Net Sales Growth Historical
This is a weighted average of the Historical Growth of Net Sales. This indicator focuses on the ability of the company to grow its Net Sales year over year, historically. Up to five years of Historical Net Sales Growth are taken into account.
Calculation: (using up to 5 years of historical data when available)
[Net Sales Growth year N*5 + Net Sales Growth year (N-1)*4 + Net Sales Growth year (N-2)*3 + Net Sales Growth year (N-3)*2 + Net Sales Growth (N-4)] / 15

Net Income Growth Historical
This is a weighted average of the Historical Growth of Net Income. This indicator focuses on the ability of the company to grow its Net Income, year over year, historically. Up to five years of historical Net Income Growth are taken into account.
Calculation: (using up to 5 years of historical data when available)
[ Net Profit Growth year N*5 + Net Profit Growth year (N-1)*4 + Net Profit Growth year (N-2)*3 + Net Profit Growth year(N-3)*2 + Net Profit Growth (N-4)]/15

Net Sales Growth Estimate
This is a Forecast CAGR (Compound Annual Growth Rate) of Net Sales Estimates.
Calculation: (using up to 3 years of forecast data when available)
(Net Sales year (N+2) – Net Sales year N)(1/2)

EPS Growth Estimate
This is a Forecast CAGR (Compound Annual Growth Rate) of EPS estimates.
Calculation: (using up to 3 years of forecast data when available)
(EPS year (N+2) – EPS year N)(1/2)